home / stock / axgn / axgn quote
Last: | $6.66 |
---|---|
Change Percent: | -0.45% |
Open: | $6.66 |
Close: | $6.66 |
High: | $6.87 |
Low: | $6.49 |
Volume: | 259,831 |
Last Trade Date Time: | 04/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.66 | $6.66 | $6.66 | $6.87 | $6.49 | 259,831 | 04-29-2024 |
$6.63 | $6.53 | $6.63 | $6.7 | $6.4301 | 421,184 | 04-26-2024 |
$6.52 | $6.72 | $6.52 | $6.87 | $6.46 | 232,933 | 04-25-2024 |
$6.87 | $6.93 | $6.87 | $6.98 | $6.82 | 120,303 | 04-24-2024 |
$6.97 | $6.84 | $6.97 | $7.15 | $6.78 | 166,479 | 04-23-2024 |
$6.86 | $6.54 | $6.86 | $6.87 | $6.45 | 408,495 | 04-22-2024 |
$6.5 | $6.45 | $6.5 | $6.6 | $6.3 | 332,067 | 04-19-2024 |
$6.55 | $6.89 | $6.55 | $6.9461 | $6.49 | 238,245 | 04-18-2024 |
$6.94 | $7.06 | $6.94 | $7.145 | $6.92 | 168,441 | 04-17-2024 |
$7 | $6.97 | $7 | $7.13 | $6.9 | 258,443 | 04-16-2024 |
$7.03 | $7.22 | $7.03 | $7.24 | $6.95 | 159,626 | 04-15-2024 |
$7.21 | $7.27 | $7.21 | $7.28 | $6.96 | 276,827 | 04-12-2024 |
$7.34 | $7.53 | $7.34 | $7.62 | $7.245 | 191,113 | 04-11-2024 |
$7.5 | $7.81 | $7.5 | $7.86 | $7.48 | 160,252 | 04-10-2024 |
$8.03 | $7.94 | $8.03 | $8.08 | $7.91 | 179,228 | 04-09-2024 |
$7.92 | $7.84 | $7.92 | $7.98 | $7.78 | 789,608 | 04-08-2024 |
$7.8 | $7.7 | $7.8 | $7.91 | $7.62 | 1,409,924 | 04-05-2024 |
$7.76 | $8.16 | $7.76 | $8.25 | $7.7 | 332,857 | 04-04-2024 |
$8.06 | $7.76 | $8.06 | $8.06 | $7.6995 | 388,679 | 04-03-2024 |
$7.81 | $7.77 | $7.81 | $7.85 | $7.68 | 321,428 | 04-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue MatrixȒ...
ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innova...
ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report first quarter 2024 financial results on Thursday, May 2, 2024...